Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on April 20, 2026

Apr. 20, 2026

2027 Kia Telluride Adds Hybrid Option Rated at Up to 35 MPG

Indeterminate GlobeNewswire

Apr. 20, 2026

Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth

Indeterminate GlobeNewswire

Apr. 20, 2026

Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq

Indeterminate GlobeNewswire

Apr. 20, 2026

Airsys Introduces Next-Generation LiquidRack™ Technology to Provide a Simpler Liquid Cooling Architecture for Retrofit, Edge, and Mid-Density AI Infrastructure

Indeterminate GlobeNewswire

Apr. 20, 2026

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

Indeterminate GlobeNewswire

Apr. 20, 2026

Cole West Closes on 38 Homesites in Northern Utah for New Community

Indeterminate GlobeNewswire

Apr. 20, 2026

Royale® Launches “There for All”: A New Platform Celebrating the Moments That Matter Most to Canadians

Indeterminate GlobeNewswire

Apr. 20, 2026

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies

Indeterminate GlobeNewswire

Apr. 20, 2026

Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent Interview

Indeterminate GlobeNewswire

Apr. 20, 2026

Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

Apr. 20, 2026

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Indeterminate GlobeNewswire

Apr. 20, 2026

Royale® lance « Là pour tout le monde », une nouvelle plateforme qui célèbre les moments qui comptent le plus pour les Canadiennes et Canadiens

Indeterminate GlobeNewswire

Apr. 20, 2026

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

Indeterminate GlobeNewswire

Apr. 20, 2026

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

Indeterminate GlobeNewswire

Apr. 20, 2026

BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

Indeterminate GlobeNewswire

Apr. 20, 2026

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Indeterminate GlobeNewswire

Apr. 20, 2026

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

Indeterminate GlobeNewswire